Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_273326141

NICE joins forces with Canadian peer to offer scientific advice to the pharma industry

February 6, 2019
Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma

NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …

News

Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3

February 6, 2019
Research and Development Icaria, Sanofi, multiple myeloma, pharma

Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …

News
genentech_web

Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m

February 6, 2019
Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …

News
shirelabsus

Takeda ordered to pay Bayer $155.19 million over patent infringement

February 6, 2019
Research and Development Baxalta, Bayer, Nektar Therapeutics, Takeda, adynovate

A US court has ordered Takeda Pharmaceutical’s Baxalta unit to pay German firm Bayer AG $155.19 million for infringement of …

News
mr058666-web

GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion

February 6, 2019
Research and Development GSK, M7824, Merck, immunotherapy

British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …

News
harald_fricke

Czech biotech SOTIO appoints experienced immune-oncology doc as new CMO

February 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Czech biotech SOTIO has announced the appointment of Dr Harald Fricke as the firm’s Chief Medical Officer (CMO). Dr Fricke, …

Appointment
robert_friesen

Former Ablynx exec joins Kiadis as Chief Scientific Officer

February 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma

Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …

Appointment
lilly_building_with_american_flag_web

Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials

February 5, 2019
Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma

Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). …

News
astrazeneca_building_white

AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug

February 5, 2019
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus

It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …

News

More than 200 Xanax-related deaths in UK since 2015

February 5, 2019
Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax

There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015. …

News
opioid_pills

Reformulated OxyContin led to spike in Hepatitis C infections

February 5, 2019
Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids

Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …

News
bernie_in_phoenix_2015_2

Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free

February 5, 2019
Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing

Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …

News
alexander_hardy

Alexander Hardy returns to Genentech as new CEO

February 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …

Appointment

Positive CHMP recommendation for Sanofi’s atherosclerotic CVD drug Praluent

February 4, 2019
Sales and Marketing Europe, atherosclerotic cardiovascular disease, cvd, pharma, praluent

It has been announced that Sanofi’s Praluent (alirocumab) has been awarded a positive recommendation from the European Medicines Agency’s Committee …

News
falsified_medicines

Counterfeit drugs – countering the lies

February 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …

Feature
shutterstock_243110086_3

100,000 extra GP appointments to be made available in Gloucestershire as part of NHS Long Term Plan

February 4, 2019
Sales and Marketing GP, Gloucestershire, NHS, UK, britain, primare care

GP practices in Gloucestershire are set to offer 100,000 more appointments for patients in the coming year. The initiative comes …

News
alk_logo_32_nodith

FDA knocks back Alkermes’ opioid-based depression therapy over lack of evidence

February 4, 2019
Sales and Marketing Alkermes, FDA, major depressive disorder, pharma, rejection

Alkermes experimental opioid-based depression therapy ALKS 5461 has been rejected by the FDA, it has emerged, in the adjunctive treatment …

News
schizophrenia_fmri_working_memory

Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials

February 4, 2019
Sales and Marketing UK, clinical trials, clozapine, mental health, schizophrenia

The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …

News
acute_lymphoblastic_leukaemia_smear

Obesity-related cancers on the rise amongst millennials

February 4, 2019
Sales and Marketing Cancer, obesity, oncology, young people

Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …

News
janssen_latest_logo_on_sign_closer

Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019
Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026